Sign in to continue:

Friday, March 13th, 2026

M3-Brigade Acquisition V Corp. 2025 Annual Report: Business Combination with ReserveOne, Shareholder Rights, and Key Risks Overview




M3-Brigade Acquisition V Corp. Annual Report: Key Investor Takeaways

M3-Brigade Acquisition V Corp. (MBAV) Annual Report – Key Investor Insights and Shareholder Guidance

By: Financial Reporter


Executive Summary

M3-Brigade Acquisition V Corp. (“MBAV” or “the Company”) has released its Annual Report on Form 10-K for the fiscal year ended December 31, 2025. As a blank check company formed to pursue a business combination, MBAV is currently in the process of seeking to merge with ReserveOne, Inc. This article summarizes the key details, material risks, and shareholder information contained in the annual report, with a focus on issues that may significantly impact shareholder value and trading in MBAV securities.


Key Highlights

  • Blank Check Company Structure: MBAV is a Cayman Islands exempted company formed on March 12, 2024. The Company has not commenced operations or generated revenues. Its sole purpose is to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.
  • Proposed Business Combination: MBAV is pursuing a combination with ReserveOne, Inc., a Delaware corporation. The transaction is not yet complete and is subject to various closing conditions and shareholder approval.
  • Trust Account Status: As of December 31, 2025, approximately \$306.88 million is held in trust, earning interest. The Company also holds approximately \$1.18 million in its operating bank account and reports a working capital deficit of \$5.6 million.
  • Share Structure: As of March 12, 2026, MBAV had 28,750,000 Class A ordinary shares (public shares) and 7,187,500 Class B founder shares outstanding. Both classes are \$0.0001 par value per share.
  • Listing and Securities:
    • Units (MBAV): Each unit consists of one Class A share and one-half of one redeemable warrant, listed on Nasdaq.
    • Warrants (MBAVW): Each whole warrant is exercisable for one Class A share at \$11.50 per share, also listed on Nasdaq.
  • PIPE Financing: On July 7, 2025, MBAV entered into equity PIPE (Private Investment in Public Equity) Subscription Agreements with certain investors. The PIPE is contingent upon satisfaction of all closing conditions for the ReserveOne transaction.
  • Redemption and Liquidation: If MBAV does not complete a business combination by August 2, 2026, the Company will redeem 100% of the public shares for cash, leading to liquidation.

Material Shareholder Information & Price-Sensitive Issues

1. Status of the ReserveOne Business Combination

  • The business combination with ReserveOne is not guaranteed and remains subject to regulatory approvals, closing conditions, and shareholder votes.
  • Forward-looking statements in the annual report highlight that any failure to close the ReserveOne deal could significantly impact MBAV’s share price, especially given the lack of alternative business operations.
  • PIPE financing is also conditional on the deal closing. Failure or delay in the PIPE or main transaction may affect liquidity and valuation.

2. Redemption Rights and Risks to Investors

  • Public shareholders have the right to redeem their Class A shares for a pro rata portion of the trust account if they do not wish to participate in the business combination.
  • Excessive redemptions may prevent MBAV from satisfying minimum cash conditions required by ReserveOne, potentially terminating the transaction and leading to liquidation.
  • MBAV’s founder shares (Class B) and the sponsor will vote in favor of any proposed business combination, regardless of public shareholder votes.

3. Potential Dilution and Capital Structure Concerns

  • The sponsor’s nominal purchase price for founder shares may result in significant dilution to public investors upon completion of a business combination.
  • If PIPE or other side investments are required to meet closing conditions, further dilution is possible.
  • The deferred underwriting fee will not be reduced by redemptions, so non-redeeming holders may see a lower per-share value post-combination.

4. Regulatory and Delisting Risks

  • There is risk that MBAV could be delisted from Nasdaq, especially if too many shares are redeemed or if the company fails to complete a business combination.
  • Delisting would significantly reduce liquidity and may force investors to sell at a loss.

5. Sponsor and Insider Purchases

  • The sponsor, initial shareholders, and affiliates may purchase shares or warrants in the open market or via private transactions. Such purchases may influence the outcome of business combination votes and reduce the public float.
  • Any purchases will be disclosed in SEC filings and must comply with federal securities laws (including Regulation M and Rule 14e-5).

6. Shell Company Status and Rule 419 Exemption

  • MBAV is a “shell company” and is exempt from certain SEC investor protections applicable to “blank check” companies under Rule 419. This means:

    • Investors do not receive certain protections (such as release of trust interest only upon combination completion).
    • MBAV has a longer period to complete a combination than Rule 419 companies.

7. Tax and Jurisdictional Risks

  • The company’s structure or business combination may result in MBAV being classified as a Passive Foreign Investment Company (“PFIC”), which could have negative tax consequences for U.S. investors.
  • MBAV may reincorporate or redomicile, potentially resulting in shareholder taxes or uncertainty.

8. Competition and Target Selection

  • MBAV faces competition from other SPACs, private equity, and strategic acquirers for business combination targets. This may affect the quality and pricing of any eventual deal.

9. Financial Reporting and Transparency

  • MBAV is required to file annual and quarterly reports with the SEC. Audited financials of the target (ReserveOne) will be included in the proxy materials provided to shareholders.
  • The pool of potential business combination targets may be limited by the requirement to provide financials prepared under U.S. GAAP or IFRS and audited to PCAOB standards.

Risks Summary

  • MBAV is an early-stage, pre-revenue company entirely dependent on successfully completing a business combination within the mandated time frame.
  • Shareholder value is highly sensitive to the outcome of the ReserveOne transaction, redemption levels, and regulatory and market conditions.
  • Any delays, failed votes, or inability to close the deal may result in forced liquidation and a return of trust proceeds, which may be below the current market price for public shares.
  • Significant dilution is possible for public shareholders, especially if additional shares/warrants are issued or if the sponsor’s founder shares convert.
  • Unusual tax consequences may arise due to PFIC status or jurisdictional changes.

Conclusion and Investor Considerations

Investors in MBAV should monitor the progress of the ReserveOne business combination, redemption levels, and any SEC or Nasdaq developments closely. The stock price may react sharply to news regarding the business combination’s likelihood, PIPE funding, or regulatory developments. The structure of MBAV’s SPAC model means shareholder value is closely tied to deal execution and capital structure management. Investors should review all SEC filings and be aware of their redemption rights and the associated deadlines.


Disclaimer: This summary is for informational purposes only and does not constitute investment, legal, or tax advice. Investors should review the full SEC filings and consult their own advisors before making any investment decisions. The author and publisher assume no liability for any actions taken based on this summary.




View M3-Brigade Acquisition V Corp. Historical chart here



Great Elm Capital Corp. 2025 Investments & Secured Loan Portfolio Overview – 10-K Filing Analysis

Great Elm Capital Corp. (GECC) 10-K Report: Key Highlights f...

Pliant Therapeutics Reports Q4 2025 Financial Results and Corporate Update – 8-K Filing Summary

Pliant Therapeutics Reports Fourth Quarter 2025 Financial Re...

Vista Gold Announces 2025 Financial Results and Progress Toward Mt Todd Gold Project Development in Australia

Vista Gold Corp Announces 2025 Financial Results and Strateg...

   Ad